Evaluation of cytotoxicity of new trans-palladium(II) complex in human cells in vitro

Acta Poloniae Pharmaceutica - Drug Research

Volumn 68, Issue 1, 2011, Pages 127-136

  Kontek, Renata ^a   Matławska Wasowska, Ksenia ^a   Kalinowska Lis, Urszula ^b   Kontek, Bogdan ^a   Ochocki, Justyn ^b  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis necrosis; MTT assay; trans palladium(II)

Indexed keywords

PALLADIUM CHLORIDE DIETHYL(PYRIDIN 2 YLMETHYL)PHOSPHATE; PALLADIUM COMPLEX; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HT29 CELLS; HUMANS; LYMPHOCYTES; NECROSIS; NEOPLASMS; PALLADIUM; PHOSPHORIC ACID ESTERS;

EID: 79551502375     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Kalinowska U., Chȩcińska L., Małecka M., Erxleben A., Lippert B., Ochocki J.: Inorg. Chim. Acta 358, 2464 (2005).
2. Al-Allaf T.A., Rashan L.J.: Boll. Chim. Farm. 140, 205 (2001).
3. Lippert B. (Ed.).: Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug. VHCA & Wiley-VCH, Zurich 1999.
4. Hartmann I.T., Lipp H.P.: Expert Opin. Pharmacother. 4, 889 (2003).
5. Kosmider B., Wyszynska K., Janik-Spiechowicz E., Osiecka R., Zyner E., Ochocki J., Ciesielska E., Wasowicz W.: Mutat. Res. 558, 93 (2004).
6. Akdi K., Vilaplana R.A., Kamah S., Navarro J.A., Salas J.M., Gonzalez-Vilchez F.J.: Inorg. Biochem. 90, 51 (2002).
7. Ramos-Lima F.J., Vrana O., Quiroga A.G., Navarro-Ranninger C., Halàmikovà A., Rybnićkovà H., Hejmalovà L., Brabec V.: J. Med. Chem. 49, 2640 (2006).
8. Perez J.M., Fuertes M.A., Alonso C., Navarro-Ranninger C.: Crit. Rev. Oncol/Hematol. 35, 109 (2000).
9. Farrell N., Povirk L.F., Dange Y., DeMasters G., Gupta M.S., Kohlahagen G., Khan Q.A., Pommier Y., Gewirtz D.A.: Biochem. Pharmacol. 68, 857 (2004).
10. Kuduk-Jaworska J., Puszko A., Kubiak M., Pełczyńska M.: J. Inorg. Biochem. 98, 1447 (2004).
11. Marzano C., Fregona D., Baccichetti F., Trevisan A., Giovagnini L., Bordin F.: Chem. Biol. Interact. 140, 215 (2002).
12. Jakupec M.A., Galanski M., Keppler B.K.: Rev. Physiol. Biochem. Pharmacol. 146, 1 (2003).
13. Kosmider B., Zyner E., Osiecka R., Ochocki J.: Can. J. Physiol. Pharmacol. 82, 353 (2004).
14. Zhao G., Lin H.: Curr. Med. Chem. Anticanc. Agents 5, 137 (2005).
15. Kalinowska U., Ochocki J., Matlawska-Wasowska K.: Coordination Chem. Revs. 252, 1328 (2008).
16. Quiroga A.D., Navarro-Ranninger C.: Coordination Chem. Revs. 248, 119 (2004).
17. Daghriri H., Huq F., Beale P.: J. Inorg. Biochem. 98, 1722 (2004).
18. Quiroga A.G., Perez J.M., Montero E.I., West D.X., Alonso C., Navarro-Ranninger C.: J. Inorg. Biochem. 75, 293 (1999).
19. Matesanz A.I., Perez J.M., Navarro P., Moreno J.M., Colacio E., Souza P.: J. Inorg. Biochem.76, 29 (1999).
20. Kovala-Demertzi D., Domopoulou A., Demertsiz M.A., Valle G., Papageorgiu A.: J. Inorg. Biochem. 68,147(1997).
21. Tušek-Božić L., Ćurić M., Balzarini J., de Clerq E.: Nucleosides Nucleotides 14, 777 (1995).
22. Kostka B., Ochocki J.: Pharmazie 51, 990 (1996).
23. Aranowska K., Graczyk J., Chȩcińska L., Pakulska W., Ochocki J.: Pharmazie 61, 457 (2006).
24. Kalinowska U., Matlawska K., Chȩcińska L., Domagała M., Kontek R., Osiecka R., Ochocki J.: J. Inorg. Biochem. 99, 2024 (2005).
25. Carmichael J., DeGraff W., Gazdar A.F., Minna J.D., Mitchell J.B.: Cancer Res. 47, 936 (1987).
26. Vermes I., Haanen C.: Adv. Clin. Chem. 31, 177 (1994).
27. Vermes I., Haanen C., Ruetelingsperger C.: J. Immunol. Methods 243, 167 (2000).
28. Kosmider B., Osiecka R., Ciesielska E., Szmigiero L., Zyner E., Ochocki J.: Mutat. Res. 558, 169 (2004).
29. Frankfurt O.S., Krishan A.: Anticancer Drugs 14, 555 (2003).
30. Alley M.C., Scudiero D.A., Monks A., Hursey M.I., Czerwiński M.J., Fine D.I., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R.: Cancer Res. 48, 589 (1988).
31. Abe K., Matsuki N.: Neurosci. Res. 38, 325 (2000).
32. Yang D., Cardona D.L., Barile F.A.: Toxicol. in Vitro 16, 33 (2002).
33. Ga̧siorowski K., Brokos B., Kulma A., Ogorzalek A., Skórkowska K.: Cell Mol. Biol. Lett. 6, 141 (2001).
34. Johnson V.J., Kim S.H., Sharma R.P.: Toxicol. Sci. 83, 329 (2005).
35. Kostova I.: Recent Patents on Anticancer Drug Discovery 1, 1 (2006).
36. Matławska-Wa̧sowska K.: Ph. D. thesis. University of Lodz, 2006.
37. Zhao G., Lin H., Yu P., Sun H., Zhu S., Su X., Chen Y.: J. Inorg. Biochem. 73, 145 (1999).
38. Kasparkova J., Marini V., Najajreh Y., Gibson D., Brabec V.: Biochemistry 42, 6321 (2003).
39. Khazanov E., Barenholz Y., Gibson D., Najajreh Y.: J. Med. Chem. 45, 196 (2002).
40. Ramos-Lima F.J., Quiroga A.G., Perez J., Navarro-Ranninger C.: Polyhedron 22, 3379 (2003).
41. Budzisz E., Krajewska U., Różalski M., Szulawska A., Czyż M., Nawrot B.: Eur. J. Pharmacol. 502, 59 (2004).
42. Quiroga A.G., Perez J.M., Lopez-Solera I., Masaguer J.R., Luque A., Roman P., Edwards A., et al.: J. Med. Chem. 41, 1399 (1998).
43. Mock Ch., Puscasu I., Rauterkus M.J., Tallen G., Wolff J.E.A., Krebs B.: Inorg. Chim. Acta 319, 109 (2001).
44. Iakovidou Z., Papageorgiou A., Demertzis M.A., Mioglou E., Mourelatos D., Kotsis A., Hath Yadav P., Kovala-Demertzi D.: Anticancer Drugs 12, 65 (2001).
45. Brudzińska I., Mikata Y., Obata M., Ohtsuki C., Yano S.: Bioorg. Med. Lett. 14, 2533 (2004).
46. Faraglia G., Fregona D., Sitran S., Giovagnini L., Marzano C., Baccichetti F., Casellato U., Graziani R.: J. Inorg. Biochem. 83, 31 (2001).
47. Bernstein C., Bernstein H., Payne C.M., Garewal H.: Mutat. Res. 511, 145 (2002).
48. Lieberthal W., Triaca V., Levine J.: Am. Physiol. Soc. 3, F700 (1996).
49. De Vizcaya-Ruiz A., Rivero-Muller A., Ruiz-Ramirez L., Kass G.E.N., Kelland L.R., Orr R.M., Dobrota M.: Toxicol. in Vitro 14, 1 (2000).
50. Bellone G., Garbone A., Sibona N., Bosco O., Tibaudi D., Smirne C., Martone T. et al.: Cancer Res. 61, 2200 (2001).
51. Liu W., Davis D.W., Ramirez K., McConkey D.J., Ellis L.M.: Int. J. Cancer 92, 26 (2001).
52. Martinez A., Lorenzo J., Prieto M.J., de Liorens R., Font-Bardia M., Solans X., Aviles F.X., Moreno V.: Chem. Biol. Chem. 6, 2068 (2005).
53. Colangelo D., Ghiglia A.L., Viano I., Mahboobi H., Ghezzi A.R., Cassino C., Osella D.: J. Inorg. Biochem. 98, 61 (2004).